Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.

Krämer, B K; Neumayer, H-H; Stahl, R; Pietrzyk, M; Krüger, B; Pfalzer, B; Bourbigot, B; Campbell, S; Whelchel, J; Eris, J; Vitko, S; Budde, K

Krämer, B K; Neumayer, H-H; Stahl, R; Pietrzyk, M; Krüger, B; Pfalzer, B; Bourbigot, B; Campbell, S; Whelchel, J; Eris, J; Vitko, S; Budde, K.

Affiliation

Krämer BK; Transplant Centre Regensburg, Regensburg, Germany. bernhard.kraemer@klinik.uni-regensburg.de

Transplant Proc ; 37(3): 1601-4, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15866684

Subject(s)

Antibodies, Monoclonal/therapeutic use; Cardiovascular Diseases/epidemiology; Cyclosporine/therapeutic use; Gonadal Steroid Hormones/blood; Kidney Transplantation/physiology; Postoperative Complications/epidemiology; Recombinant Fusion Proteins/therapeutic use; Sirolimus/analogs & derivatives; Basiliximab; Blood Pressure; Drug Therapy, Combination; Everolimus; Female; Glomerular Filtration Rate/drug effects; Graft Rejection/epidemiology; Humans; Immunosuppressive Agents/therapeutic use; Infections/epidemiology; Kidney Function Tests; Kidney Transplantation/immunology; Male; Postoperative Complications/classification; Risk Factors; Sirolimus/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Gonadal Steroid Hormones / Recombinant Fusion Proteins / Cardiovascular Diseases / Kidney Transplantation / Cyclosporine / Sirolimus / Antibodies, Monoclonal Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Transplant Proc Year: 2005 Document type: Article Affiliation country: Germany Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links